Cargando…

Predicting brain metastases of breast cancer based on serum S100B and serum HER2

Brain metastases are a major cause of morbidity and mortality in breast cancer. The aim of the current study was to evaluate the prediction of brain metastases based on serum S100B and human epidermal growth factor receptor 2 (HER2). A total of 107 breast cancer patients were included in the current...

Descripción completa

Detalles Bibliográficos
Autores principales:	BECHMANN, TROELS, MADSEN, JONNA SKOV, BRANDSLUND, IVAN, LUND, ERIK DALSGAARD, ORMSTRUP, TINA, JAKOBSEN, ERIK HUGGER, JYLLING, ANNE MARIE BAK, STEFFENSEN, KARINA DAHL, JAKOBSEN, ANDERS
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813762/ https://www.ncbi.nlm.nih.gov/pubmed/24179506 http://dx.doi.org/10.3892/ol.2013.1536

Ejemplares similares

Prognostic impact of serum levels of EGFR and EGFR ligands in early-stage breast cancer
por: Kjær, Ina Mathilde, et al.
Publicado: (2020)

Dysregulated EGFR pathway in serum in early-stage breast cancer patients: A case control study
por: Kjær, Ina Mathilde, et al.
Publicado: (2020)

New Approach for Interpreting Changes in Circulating Tumour Cells (CTC) for Evaluation of Treatment Effect in Metastatic Breast Cancer
por: Horn, Peer, et al.
Publicado: (2014)

Quantification of Cell-Free HER-2 DNA in Plasma from Breast Cancer Patients: Sensitivity for Detection of Metastatic Recurrence and Gene Amplification
por: Sørensen, Patricia Diana, et al.
Publicado: (2015)

Phase II trial of delta-tocotrienol in neoadjuvant breast cancer with evaluation of treatment response using ctDNA
por: Kjær, Ina Mathilde, et al.
Publicado: (2023)

Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab
por: Madsen, Christine Vestergaard, et al.
Publicado: (2012)

Identification of high-risk patients by human epididymis protein 4 levels during follow-up of ovarian cancer
por: STEFFENSEN, KARINA DAHL, et al.
Publicado: (2016)

Serum vitamin K(1) associated to microangiopathy and/or macroangiopathy in individuals with and without diabetes
por: Bøgh Andersen, Ida, et al.
Publicado: (2020)

Immunohistochemical Expression of Platelet-Derived Growth Factor Receptors in Ovarian Cancer Patients with Long-Term Follow-Up
por: Madsen, Christine Vestergaard, et al.
Publicado: (2012)

Are patient-reported outcomes useful in post-treatment follow-up care for women with early breast cancer? A scoping review
por: Riis, Cathrine Lundgaard, et al.
Publicado: (2019)

Decreased concentrations of intracellular signaling proteins in colon cancer patients with BRAF mutations
por: Olsen, Dorte Aa., et al.
Publicado: (2020)

Two open-label, single arm, non-randomized phase II studies of irinotecan for the treatment of metastatic breast cancer in patients with increased copy number of the topoisomerase I gene
por: Kümler, Iben, et al.
Publicado: (2019)

Rapid SARS-CoV-2 Detection Using Electrochemical Immunosensor
por: Mojsoska, Biljana, et al.
Publicado: (2021)

Aging and menopause reprogram osteoclast precursors for aggressive bone resorption
por: Møller, Anaïs Marie Julie, et al.
Publicado: (2020)

Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer
por: Steffensen, Karina Dahl, et al.
Publicado: (2010)

Zoledronic Acid Is Not Equally Potent on Osteoclasts Generated From Different Individuals
por: Møller, Anaïs M J, et al.
Publicado: (2020)

Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy
por: Henriksen, Jon Røikjær, et al.
Publicado: (2020)

Rapid Diagnosis of Ethylene Glycol Poisoning by Urine Microscopy
por: Sheta, Hussam Mahmoud, et al.
Publicado: (2018)

Prognostic Impact of Circulating Methylated Homeobox A9 DNA in Patients Undergoing Treatment for Recurrent Ovarian Cancer
por: Faaborg, Louise, et al.
Publicado: (2022)

A variability in response of osteoclasts to zoledronic acid is mediated by smoking-associated modification in the DNA methylome
por: Tan, Qihua, et al.
Publicado: (2023)

Neoadjuvant chemotherapy and HER2 dual blockade including biosimilar trastuzumab (SB3) for HER2-positive early breast cancer: Population based real world data from the Danish Breast Cancer Group (DBCG)
por: Berg, Tobias, et al.
Publicado: (2020)

Serum S100B levels in patients with depression
por: Arora, Parul, et al.
Publicado: (2019)

Inflammatory profiles relate to survival in subtypes of amyotrophic lateral sclerosis
por: Olesen, Mads Nikolaj, et al.
Publicado: (2020)

S100 as Serum Tumor Marker in Advanced Uveal Melanoma
por: Salzmann, Martin, et al.
Publicado: (2023)

HER2-positive gastric cancer identified by serum HER2: A case report
por: SAITO, MAYUKO, et al.
Publicado: (2016)

Development of Electrochemical Immunosensors for HER-1 and HER-2 Analysis in Serum for Breast Cancer Patients
por: Wignarajah, Shayalini, et al.
Publicado: (2023)

Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients
por: Darlix, Amélie, et al.
Publicado: (2016)

Monitoring serum HER2 levels in breast cancer patients
por: Tchou, Julia, et al.
Publicado: (2015)

Elevated serum levels of S100 and survival in metastatic malignant melanoma
Publicado: (1998)

Elevated serum levels of S100 and survival in metastatic malignant melanoma
Publicado: (1998)

Elevated serum levels of S100 and survival in metastatic malignant melanoma.
por: Buer, J., et al.
Publicado: (1997)

Extracranial Sources of S100B Do Not Affect Serum Levels
por: Pham, Nancy, et al.
Publicado: (2010)

Serum S100B: A Potential Biomarker for Suicidality in Adolescents?
por: Falcone, Tatiana, et al.
Publicado: (2010)

Serum S-100B protein predicts prognosis in endogenous encephalopathy
por: Yuzawa, J, et al.
Publicado: (2004)

PD46 - Serum level of S 100 proteins in patients with asthma
por: Gioka, Theodora, et al.
Publicado: (2014)

Clinical significance of serum S100A10 in lung cancer
por: Hou, Yu-Lei, et al.
Publicado: (2021)

Serial Serum HER2 Measurements for the Detection of Breast Cancer Recurrence in HER2-Positive Patients
por: Ha, June-Hyung, et al.
Publicado: (2014)

Serum HER2 levels are increased in cats with mammary carcinomas and predict tissue HER2 status
por: Soares, Maria, et al.
Publicado: (2016)

Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer
por: Spindler, Karen Lise Garm, et al.
Publicado: (2015)

Association of S100B polymorphisms and serum S100B with risk of ischemic stroke in a Chinese population
por: Lu, Yu-Lan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eav3fid506ctmpf6av6eclh7dl